Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Innovative Clinical Sol. (OTC BB:ICSN.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: News | Profile
Location
10 Dorrance Street, Suite 400
Providence, RI 02903
Phone: (401) 831-6755
Fax: (401) 831-6758
Email: khayes@phymatrix.com
Employees (last reported count): 612
Financial Links
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Services
 ·Industry: Business Services
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 96%
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Innovative Clinical Solutions, Ltd. provides services that support the needs of the pharmaceutical and managed care industries. The Company integrates its pharmaceutical services division with its provider network management division to create innovative research solutions for its customers. The Company's services include clinical and economic research and disease management, as well as managed care functions for specialty and multi-specialty provider networks including more than 5,000 providers and over 10 million patients nationwide. The Company's components include ICSL Clinical Studies, ICSL Healthcare Research and ICSL Network Management. In July 2000, the Company announced that it and its subsidiaries commenced the implementation of a plan to restructure the Company's existing $100 million 6.75% convertible Debentures due 2003 by the filing of voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code.
More from Market Guide: Expanded Business Description

Financial Summary
Innovative Clinical Solutions provides diverse services supporting the needs of the pharmaceutical and managed care industries, including site and clinical management and multi-and single-specialty provider network management. For the nine months ended 10/31/00, revenues fell 52% to $74.7 million. Net loss before extraordinary items fell 42% to $29.3 million. Results reflect decrease service revenues. Lower loss reflect reduce expenses due to asset divestitures.
More from Market Guide: Significant Developments

Officers
FY1999 Pay

Michael Heffernan, 35
Chairman, Pres, CEO
$303K
Gary Gillheeney, 45
CFO, Treasurer
--  
Bryan Dieter, 42
CIO
220K
R. Adrian Otte, M.D, 44
COO for Clinical Studies and Healthcare Research
246K
John Wardle
COO for Provider Network Services
227K
Dollar amounts are as of 31-Jan-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:ICSN.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 25-Sep-2000
$0.03 
Recent Price$0.26 
52-Week High
on 11-Oct-2000
$2.438
Beta-1.75 
Daily Volume (3-month avg)5,136 
Daily Volume (10-day avg)8,000 
Stock Performance
52-Week Change+176.6%
52-Week Change
relative to S&P500
+271.1%
Share-Related Items
Market Capitalization$3.12M
Shares Outstanding12.0M
Float500.0K
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$4.05 
Earnings (ttm)-$3.15 
Earnings (mrq)-$0.60 
Sales (ttm)$3.46 
Cash (mrq)$0.66 
Valuation Ratios
Price/Book (mrq)0.06 
Price/EarningsN/A 
Price/Sales (ttm)0.07 
Income Statements
Sales (ttm)$106.1M
EBITDA (ttm)-$84.9M
Income available to common (ttm)-$100.2M
Profitability
Profit Margin (ttm)-94.5%
Operating Margin (ttm)-84.7%
Fiscal Year
Fiscal Year EndsJan 31
Most recent quarter31-Oct-2000
Management Effectiveness
Return on Assets (ttm)-107.04%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)0.59 
Debt/Equity (mrq)0.18 
Total Cash (mrq)$7.89M
Short Interest
As of 8-Dec-1999
Shares Short0 
Shares Short
(Prior Month)
6,000 
Daily Volume250.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 31-Oct-2000)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.